Who has invested in Gelesis?

Vitruvian Partners are named among the investors backing Gelesis.

Gelesis Funding: $100M Raised, Series D (2019)

Gelesis funding overview

Gelesis is based in Boston. Gelesis has raised $100M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series D announced in December 2019. The round record for Gelesis runs through 2019; nothing later has been disclosed. Investors on record include Vitruvian Partners.

Gelesis at a glance

Total raised: $100M
Latest round: Series D
Latest round date: December 2019
Headquarters: Boston
Notable investors: Vitruvian Partners

Frequently asked about Gelesis funding

How much has Gelesis raised?: Gelesis has raised $100M in total disclosed funding across the rounds on record.
Who has invested in Gelesis?: Vitruvian Partners are named among the investors backing Gelesis.
What was the latest Gelesis funding round?: The most recent disclosed round is a Series D, announced in December 2019.
Where is Gelesis based?: Gelesis is based in Boston.
When did Gelesis last raise?: The last disclosed Gelesis round closed in December 2019 at Series D.

Gelesis totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Boston below to benchmark round size and investor mix.

Gelesis Funding: $100M Raised, Series D (2019)

Gelesis funding overview

Gelesis at a glance

Frequently asked about Gelesis funding

Companies related to Gelesis (36)

Browse related funding lists (6)